Citation Impact
Citing Papers
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice
2005 StandoutScience
TOR Signaling in Growth and Metabolism
2006 Standout
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes
2011
AGEs and Diabetic Retinopathy
2010
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: Establishment of structure–activity relationships in vitro
2007
Evidence that glucagon stimulates insulin secretion through its own receptor in rats
1995
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes
2004
Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway
2005
Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4
1996 Standout
Chitosan in nasal delivery systems for therapeutic drugs
2014
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Pattern Recognition Receptors and Inflammation
2010 Standout
Exendin-4 Decelerates Food Intake, Weight Gain, and Fat Deposition in Zucker Rats
2000
G Protein-coupled Receptors Mediate Two Functionally Distinct Pathways of Tyrosine Phosphorylation in Rat 1a Fibroblasts
1997 StandoutNobel
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
2005
Effectiveness of progressive dose‐escalation of exenatide (exendin‐4) in reducing dose‐limiting side effects in subjects with type 2 diabetes
2004
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Nanocarriers’ entry into the cell: relevance to drug delivery
2009
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
1998
Pathologies Involving the S100 Proteins and Rage
2007
The role of gut hormones in glucose homeostasis
2007
Biology of Incretins: GLP-1 and GIP
2007 Standout
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response
2004
Neurodegeneration and Inflammation
2008
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Diabetic neuropathy: clinical manifestations and current treatments
2012
Nanotechnology: Intelligent Design to Treat Complex Disease
2006
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
2009
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
How were new medicines discovered?
2011 Standout
A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes
2006 Standout
Polycystic Ovary Syndrome
2005 Standout
Abnormal splicing of the leptin receptor in diabetic mice
1996 StandoutNature
Tissue-specific Expression of Unique mRNAs That Encode Proglucagon-derived Peptides or Exendin 4 in the Lizard
1997
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
2010 Standout
Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes
2005
Uniquantal Release through a Dynamic Fusion Pore Is a Candidate Mechanism of Hair Cell Exocytosis
2014 StandoutNobel
The Physiology of Glucagon-like Peptide 1
2007 Standout
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
What We Talk About When We Talk About Fat
2014 Standout
Dose–response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats
2005
Visualizing Superoxide Production in Normal and Diabetic Rat Islets of Langerhans
2003
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy
2016
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
BMAL1 and CLOCK, Two Essential Components of the Circadian Clock, Are Involved in Glucose Homeostasis
2004
Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide
1995
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
2003
A role for glucagon-like peptide-1 in the central regulation of feeding
1996 StandoutNature
Molecular cloning and single-channel properties of the cyclic nucleotide-gated channel from catfish olfactory neurons
1992 StandoutNobel
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
2017
Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level
2006
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
2009
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance
2002
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
2001
Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model
2011
Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists
1984 Nature
Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products
2004
Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
1998 StandoutNobel
ADrosophilaCalcium Channel α1 Subunit Gene Maps to a Genetic Locus Associated with Behavioral and Visual Defects
1996 StandoutNobel
Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas
1995
Restoration of leptin responsiveness in diet‐induced obese mice using an optimized leptin analog in combination with exendin‐4 or FGF21
2012
Nonviral Vectors for Gene Delivery
2008 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Local Expression of B7-H4 by Recombinant Adenovirus Transduction in Mouse Islets Prolongs Allograft Survival
2009
A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice
2005 StandoutNobel
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
2004
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel
1988
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia
2004
Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells
2004
RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
2014
Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes
2003
Checkpoints in the progression of autoimmune disease: lessons from diabetes models.
1996
RAGE Control of Diabetic Nephropathy in a Mouse Model
2006
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome
2003
Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity
2002
Mechanisms of Diabetic Complications
2013 Standout
Glucose Competence of the Hepatoportal Vein Sensor Requires the Presence of an Activated Glucagon-Like Peptide-1 Receptor
2001
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes
2005
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus
2005
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
1998 Standout
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
2004 Standout
Three types of neuronal calcium channel with different calcium agonist sensitivity
1985 StandoutNature
Development and Characterization of a Glucagon-Like Peptide 1-Albumin Conjugate
2003
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo
2010
Gut hormone PYY3-36 physiologically inhibits food intake
2002 StandoutNature
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea
2005
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
2011
Works of Thomas Linn being referenced
Insulin Containing Nanocomplexes Formed by Self-Assembly from Biodegradable Amine-Modified Poly(Vinyl Alcohol)-Graft-Poly(l-Lactide): Bioavailability and Nasal Tolerability in Rats
2005
Uptake and Transport of PEG-Graft-Trimethyl-Chitosan Copolymer–Insulin Nanocomplexes by Epithelial Cells
2005
Superoxide dismutase in the nonobese diabetic (NOD) mouse: A dynamic time-course study
1995
Diet Promotes β-Cell Loss by Apoptosis in Prediabetic Nonobese Diabetic Mice1
1999
Intercellular adhesion molecule-1 (ICAM-1) expression in the islets of the non-obese diabetic and low-dose streptozocin-treated mouse
1994
Effect of long-term dietary protein intake on glucose metabolism in humans
2000
Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: A randomized, controlled, prospective study over 5 years in newly diagnosed patients
1996
Hyperglycaemic memory affects the neurovascular unit of the retina in a diabetic mouse model
2017
Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets
2006
Temperature‐dependent regulation of d‐cis‐[3H]diltiazem binding to Ca2+ channels by 1,4‐dihydropyridine channel agonists and antagonists
1983
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins
2003
Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus.
1996
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
1993